Novel compounds exhibit selective cytotoxicity against HeLa cells, indicating potential for cancer treatment.
Nine novel functionalized 2,5-diaryloxazolo[4,5- d ]pyrimidin-7-ylamines were designed, synthesized and characterized using 1 H, 13 C NMR, IR spectroscopy, elemental analysis, and liquid chromatography–mass spectrometry . Their anticancer activity was assessed against human cancer cell as well as non-cancer cell lines. Three compounds, 1 , 3 , and 9 , were the most cytotoxic to HeLa cells (IC 50 = 6.13 ± 1.95, 13.99 ± 1.80 and 49.92 ± 3.98 μM, respectively). However, only compounds 1 , 7 , and 9 were selective against the tested lines. Compound 9 can be classified as the most attractive and promising candidate for further development against cervical adenocarcinoma.
No takes yet. Share an insight, caveat, or question.
Hodyna et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: